ID

38222

Description

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02053636

Lien

https://clinicaltrials.gov/show/NCT02053636

Mots-clés

Versions (1)
  1. 29/09/2019 29/09/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

29 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT02053636

Anglais

Eligibility Breast Cancer NCT02053636

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed breast adenocarcinoma.
Description

Breast adenocarcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C0858252
presence of an accessible metastatic lesion for biopsy or at least one archived metastatic tumour sample.
Description

Metastatic Lesion Amenable Biopsy | Tumor tissue sample metastatic Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513183
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C0005558
UMLS CUI [2,1]
C0475358
UMLS CUI [2,2]
C1522484
UMLS CUI [2,3]
C1265611
prior first-line hormonal therapy in the metastatic setting.
Description

First line Hormone Therapy Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0027627
demonstrated progression of disease by radiological or clinical assessment.
Description

Disease Progression

Type de données

boolean

Alias
UMLS CUI [1]
C0242656
female patient, aged ≥18 years old.
Description

Gender | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
estimated life expectancy >3 months.
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
normal left ventricular function
Description

Left Ventricular Function

Type de données

boolean

Alias
UMLS CUI [1]
C0080310
adequate haematological, hepatic and renal functions.
Description

Hematologic function | Liver function | Renal function

Type de données

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
for women with childbearing potential, a negative pregnancy test prior to initiation of the study drug and willingness to use an effective contraception.
Description

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
ability to swallow oral capsules.
Description

Able to swallow Capsules

Type de données

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0006935
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than two lines of chemotherapy and two lines of hormonal therapy with or without targeted therapy in the metastatic setting.
Description

Chemotherapy Quantity Neoplasm Metastasis | Hormone Therapy Quantity Neoplasm Metastasis | Targeted Therapy Neoplasm Metastasis | Targeted Therapy Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0027627
UMLS CUI [3,1]
C2985566
UMLS CUI [3,2]
C0027627
UMLS CUI [4,1]
C2985566
UMLS CUI [4,2]
C0332197
previous treatment with bevacizumab within 3 months of first dose of investigational medicinal product.
Description

bevacizumab

Type de données

boolean

Alias
UMLS CUI [1]
C0796392
active central nervous system metastases, cerebral oedema, and/or progressive growth.
Description

CNS metastases | Cerebral Edema | Growth Progressive

Type de données

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2]
C0006114
UMLS CUI [3,1]
C0018270
UMLS CUI [3,2]
C0205329
patients with impaired cardiac function.
Description

Decreased cardiac function

Type de données

boolean

Alias
UMLS CUI [1]
C0232166
uncontrolled arterial hypertension
Description

Uncontrolled hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C1868885
patients with history of thrombotic disorders or hereditary risk factors of thromboembolic events
Description

Thrombosis | Risk factors Hereditary Thromboembolic event

Type de données

boolean

Alias
UMLS CUI [1]
C0040053
UMLS CUI [2,1]
C0035648
UMLS CUI [2,2]
C0439660
UMLS CUI [2,3]
C0040038
serum potassium level below lower limit of normal
Description

Serum potassium decreased

Type de données

boolean

Alias
UMLS CUI [1]
C0595885
uncontrolled hypothyroidism.
Description

Hypothyroidism Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020676
UMLS CUI [1,2]
C0205318
pregnant or breastfeeding women.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT02053636

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma
Item
histologically confirmed breast adenocarcinoma.
boolean
C0858252 (UMLS CUI [1])
Metastatic Lesion Amenable Biopsy | Tumor tissue sample metastatic Quantity
Item
presence of an accessible metastatic lesion for biopsy or at least one archived metastatic tumour sample.
boolean
C1513183 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
C0475358 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
First line Hormone Therapy Neoplasm Metastasis
Item
prior first-line hormonal therapy in the metastatic setting.
boolean
C1708063 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Disease Progression
Item
demonstrated progression of disease by radiological or clinical assessment.
boolean
C0242656 (UMLS CUI [1])
Gender | Age
Item
female patient, aged ≥18 years old.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Life Expectancy
Item
estimated life expectancy >3 months.
boolean
C0023671 (UMLS CUI [1])
Left Ventricular Function
Item
normal left ventricular function
boolean
C0080310 (UMLS CUI [1])
Hematologic function | Liver function | Renal function
Item
adequate haematological, hepatic and renal functions.
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
for women with childbearing potential, a negative pregnancy test prior to initiation of the study drug and willingness to use an effective contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Able to swallow Capsules
Item
ability to swallow oral capsules.
boolean
C2712086 (UMLS CUI [1,1])
C0006935 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Quantity Neoplasm Metastasis | Hormone Therapy Quantity Neoplasm Metastasis | Targeted Therapy Neoplasm Metastasis | Targeted Therapy Absent
Item
more than two lines of chemotherapy and two lines of hormonal therapy with or without targeted therapy in the metastatic setting.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
C2985566 (UMLS CUI [3,1])
C0027627 (UMLS CUI [3,2])
C2985566 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
bevacizumab
Item
previous treatment with bevacizumab within 3 months of first dose of investigational medicinal product.
boolean
C0796392 (UMLS CUI [1])
CNS metastases | Cerebral Edema | Growth Progressive
Item
active central nervous system metastases, cerebral oedema, and/or progressive growth.
boolean
C0686377 (UMLS CUI [1])
C0006114 (UMLS CUI [2])
C0018270 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
Decreased cardiac function
Item
patients with impaired cardiac function.
boolean
C0232166 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled arterial hypertension
boolean
C1868885 (UMLS CUI [1])
Thrombosis | Risk factors Hereditary Thromboembolic event
Item
patients with history of thrombotic disorders or hereditary risk factors of thromboembolic events
boolean
C0040053 (UMLS CUI [1])
C0035648 (UMLS CUI [2,1])
C0439660 (UMLS CUI [2,2])
C0040038 (UMLS CUI [2,3])
Serum potassium decreased
Item
serum potassium level below lower limit of normal
boolean
C0595885 (UMLS CUI [1])
Hypothyroidism Uncontrolled
Item
uncontrolled hypothyroidism.
boolean
C0020676 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial